Management of Post-Traumatic Nightmares: a Review of Pharmacologic and Nonpharmacologic Treatments Since 2013

@article{Waltman2018ManagementOP,
  title={Management of Post-Traumatic Nightmares: a Review of Pharmacologic and Nonpharmacologic Treatments Since 2013},
  author={S. Waltman and D. Shearer and Bret A. Moore},
  journal={Current Psychiatry Reports},
  year={2018},
  volume={20},
  pages={1-10}
}
Purpose of ReviewPost-traumatic nightmares (PTN) are a common and enduring problem for individuals with post-traumatic stress disorder (PTSD) and other clinical presentations. PTN cause significant distress, are associated with large costs, and are an independent risk factor for suicide. Pharmacological and non-pharmacological treatment options for PTN exist. A previous review in this journal demonstrated that Prazosin, an alpha blocker, was a preferred pharmacological treatment for PTN and… Expand
Exposure, Relaxation, and Rescripting Therapy for Trauma-Related Nightmares With Psychiatric Inpatients: A Case Series
TLDR
Some preliminary support is offered for the provision of ERRT for the treatment of trauma-related nightmares for psychiatric inpatients in a private acute care inpatient psychiatric hospital setting. Expand
Demographic Variation in the Use of Prazosin for Treatment of Sleep Disturbance in Combat Veterans with PTSD.
TLDR
Prazosin is prescribed for PTSD-SD to a diverse clinical population with multiple comorbidities and concurrent medications and is characterized by poor adherence and sub-optimal dosing. Expand
Work-related post-traumatic stress disorder: report of five cases
TLDR
It is concluded that PTSD can develop even in professional categories generally considered to be at low risk, in such cases, a correct interdisciplinary diagnostic approach is fundamental for addressing therapy and for medico-legal actions. Expand
The mechanisms of action underlying the efficacy of psychological nightmare treatments: A systematic review and thematic analysis of discussed hypotheses.
TLDR
A systematic review with a qualitative thematic analysis to identify and categorize the existing proposed mechanisms of action (MAs) of nightmare treatments revealed that an increased sense of mastery was the most often cited hypothesis to explain the efficacy of nightmare psychotherapies. Expand
The Possible Mechanism of the Appearance of Nightmares in Post-Traumatic Stress Disorder and Approaches to Their Prevention
TLDR
It is suggested that nightmares may be prevented by antagonists of dopamine D1 receptor and alpha1 adrenoceptor and agonists of glucocorticoid, serotonin 5-HT1B, and cannabinoid CB1 receptors, as well as antagonists of alpha2 adrenoreceptors and dopamine D2 receptors in order to avoid side effects. Expand
Imagery rehearsal therapy and/or mianserin in treatment of refugees diagnosed with PTSD: Results from a randomized controlled trial
TLDR
Add‐on treatment with imagery rehearsal therapy (IRT) and/or mianserin against treatment as usual (TAU) alone in a sample of trauma‐affected refugees with PTSD at 8–12 months follow-up did not find IRT or mianerin to be superior to TAU. Expand
Clinical Therapeutic Strategy and Neuronal Mechanism Underlying Post-Traumatic Stress Disorder (PTSD)
TLDR
The neuronal circuits and novel therapeutic strategies for PTSD symptoms are addressed and it is reported that ω3 long-chain polyunsaturated fatty acid (LCPUFA) supplements can suppress the development of PTSD symptoms. Expand
Sleep disturbance in post-traumatic stress disorder (PTSD): a systematic review and meta-analysis of actigraphy studies
TLDR
A systematic review and meta-analysis to determine whether there are any significant differences between individuals with and without PTSD in actigraph-derived sleep measures found no evidence of a statistically significant difference. Expand
Afraid and Awake: The Interaction Between Trauma and Sleep in Children and Adolescents.
TLDR
If a history of both trauma and sleep complaints is identified, an effective trauma-informed intervention, whether psychological, psychopharmacologic, or a combination of the two, should directly address sleep issues. Expand
Rêves et cauchemars sont-ils de nouveaux outils en thérapie cognitivo-comportementale ?
Summary A number of writers from the cognitivist movement have developed tools to tackle the dreams of their clients. As reflections of automatic thoughts or thought patterns, dreams could becomeExpand
...
1
2
...

References

SHOWING 1-10 OF 97 REFERENCES
Management of Post-Traumatic Nightmares: A Review of Pharmacologic and Nonpharmacologic Treatments Since 2010
TLDR
Pharmacologically, the medication prazosin is showing robust clinical effects with minimal side effects and Psychologically, imagery rehearsal therapy commands the greater portion of the nightmare literature due to its established efficacy. Expand
Best practice guide for the treatment of nightmare disorder in adults.
  • R. Aurora, R. Zak, +9 authors T. Morgenthaler
  • Psychology, Medicine
  • Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
  • 2010
Prazosin is recommended for treatment of Posttraumatic Stress Disorder (PTSD)-associated nightmares. Level A. Image Rehearsal Therapy (IRT) is recommended for treatment of nightmare disorder. LevelExpand
Treatment of posttraumatic stress disorder with nefazodone
TLDR
Nefazodone was associated with clinical improvement in this population of patients with PTSD, and now needs to be studied in double-blind, placebo controlled, protocols. Expand
Pilot Study: Brief Posttrauma Nightmare Treatment for Persons With Bipolar Disorder
Previous research on an efficacious cognitive-behavioral treatment for posttrauma nightmares and sleep disturbances (exposure, relaxation, and rescripting therapy; ERRT) has not tested the treatmentExpand
Use of Prazosin for Pediatric PTSD-Associated Nightmares and Sleep Disturbances: A Retrospective Chart Review
TLDR
Prazosin treatment was well-tolerated and associated with improvements in nightmares and sleep in youth with PTSD and Adverse events were consistent with the known side-effect profile of prazoin and included dizziness and nausea. Expand
Doxazosin for the treatment of nightmares: does it really work? A case report.
TLDR
Prazosin and doxazosin are both α1-adrenergic antagonists used in hypertension and BPH, and they should also inhibit adrenergic activity in the brain of patients with PTSD, which should curb this response. Expand
The Use of a Synthetic Cannabinoid in the Management of Treatment‐Resistant Nightmares in Posttraumatic Stress Disorder (PTSD)
  • G. Fraser
  • Psychology, Medicine
  • CNS neuroscience & therapeutics
  • 2009
TLDR
The results of this study indicate the potential benefits of nabilone, a synthetic cannabinoid, in patients with PTSD experiencing poor control of nightmares with standard pharmacotherapy. Expand
Position Paper for the Treatment of Nightmare Disorder in Adults: An American Academy of Sleep Medicine Position Paper.
TLDR
The American Academy of Sleep Medicine (AASM) position regarding various treatments of nightmare disorder in adults is provided and the following therapies are recommended for the treatment of PTSD-associated nightmares and nightmare disorder. Expand
Treating nightmares and insomnia in posttraumatic stress disorder: A review of current evidence
TLDR
The ability to treat PTSD-related sleep disturbances may be improved by moving away from considering sleep symptoms in isolation and instead conducting integrative studies that examine sequential or combined behavioral and/or pharmacological treatments targeting both the daytime and nighttime aspects of PTSD. Expand
Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report.
TLDR
Topiramate appeared effective as add-on or monotherapy for chronic PTSD and demonstrated a rapid onset of action and minimally serious, dose-related side effects without the development of tolerance. Expand
...
1
2
3
4
5
...